ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
With the recent sales force expansion and new product launches, we expect to be back to above-market growth
Subscribe To Our Newsletter & Stay Updated